iShares S&P Global Healthcare (IXJ)

Add to Watchlists
Create an Alert
95.41 -0.04  -0.04% NYSE Arca Oct 22, 5:01PM BATS Real time Currency in USD
View Full Chart
IXJ Price Chart

IXJ Description

iShares S&P Global Healthcare is a long only equity fund managed by iShares that tracks the S&P Global 1200 Healthcare Sector NR USD index and has 1.217B USD assets under management. It has an expected distribution yield of 1.44%, a Forecasted PE Ratio of 20.54, and a Forecasted Price to Book Value of 3.491. The fund has a net expense ratio of 0.48%, turns over its positions 5.00% per year, and is traded on the New York Stock Exchange Arca.

Benchmark Index: S&P Global 1200 Healthcare Sector NR USD

IXJ Key Info

Expense Ratio (7-31-14) 0.48%
Assets Under Management (10-17-14) 1.217B
30-Day Average Volume (10-21-14) 81505.63
Net Asset Value (10-21-14) 95.30
Discount or Premium to NAV (10-17-14) 0.09%
Turnover Ratio (3-31-14) 5.00%

IXJ Asset Allocation

Type % Net % Long % Short
Cash 0.08% 0.08% 0.00%
Stock 99.92% 99.92% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Oct. 17, 2014

IXJ Region Exposure

Americas 65.11%
North America 65.11%
Latin America 0.00%
Greater Europe 30.15%
United Kingdom 6.58%
Europe Developed 23.57%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 4.74%
Japan 3.63%
Australasia 1.11%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Oct. 17, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

IXJ Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.53%
Industrials 0.00%
Real Estate 0.00%
Technology 0.47%
Utilities 0.00%
As of Oct. 17, 2014

IXJ Stock Market Capitalization

Giant 66.26%
Large 29.34%
Medium 4.32%
Small 0.00%
Micro 0.00%
As of Oct. 17, 2014
View More Holdings

IXJ Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 7.61% 101.22 +0.85%
Novartis AG 6.43% 86.84 +0.00%
Roche Holding AG Dividend Right Cert. 5.43% 289.75 -0.43%
Pfizer Inc 4.82% 28.31 +0.11%
Merck & Co Inc 4.26% 55.52 +0.71%
Gilead Sciences Inc 4.16% 106.09 -0.54%
Sanofi 3.41% 106.22 +2.75%
Bayer AG 3.03% 133.15 +1.91%
GlaxoSmithKline PLC 2.90% 22.15 +0.23%
Amgen Inc 2.77% 143.67 -0.29%
As of Oct. 17, 2014
Get Quote for
Advertisement

IXJ Risk Info

Beta 0.7063
30 Day Average Volatility 17.79%

IXJ Fundamentals

Dividend Yield TTM (10-22-14) 1.44%
Weighted Average PE Ratio 24.56
Weighted Average Price to Sales Ratio 2.247
Weighted Average Price to Book Ratio 3.895
Weighted Median ROE 23.77%
Weighted Median ROA 9.83%
Forecasted Dividend Yield 1.78%
Forecasted PE Ratio 20.54
Forecasted Price to Sales Ratio 2.179
Forecasted Price to Book Ratio 3.491
Number of Holdings 89.00
As of Oct. 17, 2014

IXJ Growth Estimates

Forecasted 5 Yr Earnings Growth 8.95%
Forecasted Book Value Growth 7.78%
Forecasted Cash Flow Growth 1.39%
Forecasted Earnings Growth 3.58%
Forecasted Revenue Growth 6.30%
As of Oct. 17, 2014

IXJ Performance

  Returns Total Returns
1M -3.68% -3.68%
3M 1.33% 1.33%
6M 6.59% 7.71%
1Y 17.15% 18.94%
3Y 75.06% 85.73%
5Y 95.19% 116.2%
As of Oct. 21, 2014

IXJ Flows

1M 24.46M
3M 67.61M
6M 44.18M
YTD 115.36M
1Y 161.17M
3Y 293.20M
5Y 320.11M
As of Sept. 30, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.